Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-05-07

Synthesis of divergent intermediates for the generation of analogues of spicamycin for the study and treatment of cancer and tuberculosis

Objective



Research objectives and content
The synthesis of divergent intermediates for the generation of spicamycin and analogues, which may be promising as potential cancer and tuberculosis therapeutics.
Training content (objective, benefit and expected impact)
This project provides an opportunity to do exciting chemistry, using new techniques and aspects of modern synthetic and bioorganic chemistry. Links with industry / industrial relevance (22)
The project will receive an important support from pharmaceutical c companies. We will work in collaboration with their biologists.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
EU contribution
No data
Address
South Parks Road
OX1 3QY OXFORD
United Kingdom
Total cost
No data

Participants (1)